Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: A hospital based study from North India

Indian Journal of Cancer

Volumn 43, Issue 3, 2006, Pages 110-116

  Aggarwal, R ^a   Gupta, S ^a   Nijhawan, R ^a   Suri, V ^a   Kaur, A ^b   Bhasin, V ^c   Arora, Sunil K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Primary Health Center   (India)

^c Healing Touch City Clinic   (India)

Author keywords

Human papillomavirus; Polymerase chain reaction

Indexed keywords

EID: 33750690532     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509x.27932     Document Type: Article

References (35)

1. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
2. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
3. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of papillomavirus status to cervical lesions and consequences for cervical cancer screening: A prospective study. Lancet 1999;354:20-5.
4. Zur Hausen H. Immortalization of human cells and their malignant conversion by high-risk human papillomavirus genotypes. Semin Cancer Biol 1999;9:405-11.
5. Mandal R, Mittal S, Basu P. Management of cervical precancer. In: Detection, diagnosis and management of cervical intraepithelial neoplasia. Lodha ND, Kamal MM, (editors). Nagpur; 2003. p. 1.
6. Kobayashi A, Miaskowski C, Wallhagen M, Smith-McCune K. Recent developments in understanding the immune response to human papilloma virus infection and cervical neoplasia. Oncol Nurs Forum 2000;27:643-51.
7. Moscicki AB. Human papillomavirus infection in adolescents. Pediatr Clin North Am 1999;46:783-807.
8. th ed. McGraw Hill: New York; 2001. p. 1118-20.
9. Tyring SK. Human papillomavirus infection: Epidemiology, pathogenesis and host immune response. J Am Acad Dermatol 2000;43:s18-26.
10. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
11. Miller SA, Dykes D, Polesky HK. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acid Res 1988;16:1215.
12. Contorni M, Leocini P. Typing of human papillomavirus DNA by restriction endonuclease mapping of the PCR products. J Virol Methods 1993;41:29-36.
13. Oh YL, Shin KJ, Han J, Kim DS. Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening. Cytopathology 2001;12:75-83.
14. Miller CS, Zeuss MS, White DK. Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization. Oral Surg Oral Med Oral Pathol 1994;77:480-6.
15. Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 2002;78:225-8.
16. Stanley M. Genital human papillomavirus infections and prospective therapies. J Natl cancer Inst 2003;31:117-24.
17. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68:766-9.
18. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, et al Baseline cytology human papillomavirus testing and risk for cervical neoplasia: A 10 -year cohort analysis. J Natl Cancer Inst 2003;95:46-52.
19. Walker JL, Wang SS, Schiffman M, Solomon D; ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during postcolposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol 2006;195:341-8.
20. Duttagupta C, Sengupta S, Roy M, Sengupta D, Bhattacharya P, Laikangbam P, et al. Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 2004;14:293-303.
21. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case-control study. Int J Cancer 2003;107:127-33.
22. Chaouki N, Bosch FX, Munoz N, Meijer CJ, Gueddari BE, Ghazi AE, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54.
23. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
24. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 2005;366:991-8.
25. Gopalkrishna V, Aggarwal N, Malhotra VL, Koranne RV, Mohan VP, Mittal A, et al. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infect 2000;6:88-93.
26. Sarnath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, et al. HPV 16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol 2002;86:157-62.
27. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. JAMA 2002;288:1749-57.
28. Womack SD, Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, et al. Evaluation of human papillomavirus assay in cervical screening in Zimbabwe. BJOG 2000;107:33-8.
29. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chang S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. CMAJ 2000;163:503-8.
30. Maehama T, Asato T, Kanazawa K. Prevalence of HPV infection in cervical cytology -normal women in Okinawa, Japan, as determined by a polymerase chain reaction. Int J Gynecol Obestet 2000;69:175-6.
31. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 2004;90:638-45.
32. Ekalaksananan T, Pientong C, Kotimanusvanij D, Kongyingyoes B, Sriamporn S, Jintakanon D. The relationship of human papillomavirus (HPV) detection to Pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand. J Obstet Gynaecol Res 2001;27:117-24.
33. Wickenden C, Malcolm AD, Byrne M, Smith C, Anderson MC, Coleman DV. Prevalence of HPV DNA and viral copy numbers in cervical scrapes from women with normal and abnormal cervices. J Pathol 1987;153:127-35.
34. Rolon PA, Smith JS, Munoz N, Klug SJ, Herrero R, Bosch X, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000;85:486-91.
35. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombia women with normal cytology. Br J Cancer 2002;87:324-33.